P

Inventor

THOMSON STEPHEN ANDREW

US12 patents
⚠️ This page may combine multiple inventors who share the name “THOMSON STEPHEN ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VERTEX PHARMA

10 patents
US10647661B2May 12, 2020

Carboxamides as modulators of sodium channels

VERTEX PHARMA15 citations93
US12247021B2Mar 11, 2025

Substituted tetrahydrofurans as modulators of sodium channels

VERTEX PHARMA1 citations72
US11834441B2Dec 5, 2023

Substituted tetrahydrofurans as modulators of sodium channels

VERTEX PHARMA4 citations72
US11919887B2Mar 5, 2024

Substituted tetrahydrofurans as modulators of sodium channels

VERTEX PHARMA2 citations71
US11827627B2Nov 28, 2023

N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels

VERTEX PHARMA3 citations71
US11603351B2Mar 14, 2023

Carboxamides as modulators of sodium channels

VERTEX PHARMA3 citations71
US12281057B2Apr 22, 2025

Carboxamides as modulators of sodium channels

VERTEX PHARMA1 citations62
US12258333B2Mar 25, 2025

N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels

VERTEX PHARMA0 citations60
US12441703B2Oct 14, 2025

Carboxamides as modulators of sodium channels

VERTEX PHARMA0 citations50
US12440481B2Oct 14, 2025

Esters and carbamates as modulators of sodium channels

VERTEX PHARMA0 citations50

GLAXOSMITHKLINE IP DEV LTD

1 patent
US11053234B2Jul 6, 2021

1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors

GLAXOSMITHKLINE IP DEV LTD0 citations59

SMITHKLINE BEECHAM CORP

1 patent
US6589934B1Jul 8, 2003

Kv2.1 antagonists

SMITHKLINE BEECHAM CORP2 citations54